Radiology News and Research RSS Feed - Radiology News and Research

Radiology is the medical specialty directing medical imaging technologies to diagnose and sometimes treat diseases. Originally it was the aspect of medical science dealing with the medical use of electromagnetic energy emitted by X-ray machines or other such radiation devices for the purpose of obtaining visual information as part of medical imaging.

Image Wisely launches third radiation safety case

Image Wisely recently launched its third Image Wisely Radiation Safety Case — CT Brain Perfusion Dose Optimization. This is the latest in a series of free, online and mobile-compatible educational offerings, developed with the assistance of the American College of Radiology, that allow radiologists, imaging technologists and medical physicists to assess their understanding of important radiation safety concepts - including dose monitoring and optimization. [More]

Reverse Medical receives FDA IDE approval for BARREL Vascular Reconstruction Device

Reverse Medical Corporation today announced FDA IDE approval for clinical investigation of their BARREL Vascular Reconstruction Device (VRD). The BARREL Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial bifurcation aneurysms. [More]

MRI information can speed onset of effective treatments for concussion patients

Researchers using information provided by a magnetic resonance imaging (MRI) technique have identified regional white matter damage in the brains of people who experience chronic dizziness and other symptoms after concussion. [More]

Criterions EHR certified under Drummond Group's ONC-ACB program

Criterions EHR version 3.0 has been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body program. This EHR software is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of Health and Human Services. [More]
Bay Area Medical Center renews contract for Zix Email Encryption in a three-year agreement

Bay Area Medical Center renews contract for Zix Email Encryption in a three-year agreement

Zix Corporation (ZixCorp), a leader in email data protection, announced that Bay Area Medical Center has renewed its contract for ZixTM Email Encryption in a three-year agreement. [More]
UCSF launches Brain Health Registry to advance neuroscience research

UCSF launches Brain Health Registry to advance neuroscience research

A new online project led by researchers at UC San Francisco promises to dramatically cut the time and cost of conducting clinical trials for brain diseases, while also helping scientists analyze and track the brain functions of thousands of volunteers over time. [More]

First Edition: April 8, 2014

Kaiser Health News staff writer Jay Hancock reports: "Under intense, bipartisan political pressure, the Obama administration backed down for the second year in a row on proposed payment cuts for insurance companies that offer private plans to Medicare members. [More]
Dream team aims to turn pancreatic cancer into treatable disease

Dream team aims to turn pancreatic cancer into treatable disease

UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer. [More]

Vitamin D insufficiency contributes to increased 10-year fracture risk in elderly women

A study presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases shows that long-term low levels of vitamin D intake are associated with higher 10-year fracture risk in elderly women. [More]
Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. [More]
Full-field digital mammography associated with lower recall and biopsy rates, says study

Full-field digital mammography associated with lower recall and biopsy rates, says study

Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study published online in the journal Radiology. [More]
Toshiba launches sleek, lightweight ultrasound system, Xario 200

Toshiba launches sleek, lightweight ultrasound system, Xario 200

Hospitals and imaging centers of any size can now access premium image quality with Toshiba America Medical Systems, Inc.'s Xario™ 200. The all-new ultrasound system is sleek and lightweight and takes the worry out of providing high-quality patient care with a compact ultrasound system. [More]

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

MR cardiac exams are faster and more accurate with new tools from Toshiba America Medical Systems, Inc. CardioLine, now available on the Vantage Titan™ 1.5T and 3T MR systems, improves workflow and standardizes exams to meet the pressures of today's cardiology market. [More]
CT scans allow rheumatologists to diagnose gout

CT scans allow rheumatologists to diagnose gout

Gout is on the rise among U.S. men and women, and this piercingly painful and most common form of inflammatory arthritis is turning out to be more complicated than had been thought. [More]

Johns Hopkins researchers use 3-D MRI scans to accurately measure tumor viability and death

In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy - delivered directly through a tumor's blood supply - is working. [More]

Pacific Vascular purchases Toshiba's Aplio 300 ultrasound systems

Pacific Vascular, Inc. is providing its patients with the latest in ultrasound technology by acquiring 36 Aplio 300 ultrasound systems from Toshiba America Medical Systems, Inc. [More]
A fast, non-invasive method to genotype late-onset Alzheimer's disease

A fast, non-invasive method to genotype late-onset Alzheimer's disease

The apolipoprotein E gene ε4 allele is considered a negative factor for neural regeneration in late-onset Alzheimer's disease cases. [More]

Studying brain network changes in stroke patients possible with functional network connection models

Studies have shown that functional network connection models can be used to study brain network changes in patients with schizophrenia. A research team from Huazhong University of Science and Technology in China inferred that these models could also be used to explore functional network connectivity changes in stroke patients. [More]
State highlights: Fla. employees' unequal premiums; abuse by Calif. doctor alleged

State highlights: Fla. employees' unequal premiums; abuse by Calif. doctor alleged

The Florida Cabinet, state agency managers and legislative staff are among 30,000 top-ranked state workers who will continue to pay ultra-low health insurance premiums in the coming year. In a reverse of the Robin Hood principle, the state charges lower-paid workers six times more than those who have the highest earnings pay. ... [B]oth the House and Senate this week released initial budgets that would keep premiums at the same rate (3/22). [More]

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA. [More]